Clinical studies recruiting near Fayetteville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Highlands Oncology Group, PA · Pfizer · NCT07028853 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Cape Fear Valley Health System ( Site 0136) · Merck Sharp & Dohme LLC · NCT06393374 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Primeway Clinical Research- Site Number : 8400019 · Sanofi · NCT07190196 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Highlands Oncology Group, PA · Pfizer · NCT07421700 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Highlands Oncology Group, PA · Pfizer · NCT07144280 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Coastal Research Institute - Fayetteville · Eli Lilly and Company · NCT06937086 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Piedmont Fayette Hospital · NRG Oncology · NCT05174169 Persona Revision Knee System Outcomes
Phase N/A · Advanced Orthopaedic Specialists · Zimmer Biomet · NCT04821154 Targeting Components of Distress Tolerance
NA · University of Arkansas - Fayetteville · University of Arkansas, Fayetteville · NCT06570603 Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Phase 3 · Northwest Arkansas Pediatric Clinic- Site Number : 8400039 · Sanofi · NCT07348692 ERP to Improve Functioning in Veterans With OCD
NA · Fayetteville VA Medical Center, Fayetteville, NC · VA Office of Research and Development · NCT05240924 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Highlands Oncology · Pfizer · NCT06629779 A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
Phase 2 · Javara-Fayetteville-67354 · Boehringer Ingelheim · NCT07662122 A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Phase 3 · Northwest Arkansas Pediatric Clinic · Pfizer · NCT07629440 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · Cape Fear Valley Cancer Center · Boehringer Ingelheim · NCT07472517 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Piedmont Fayette Hospital · NRG Oncology · NCT03180268 Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica
Phase 1/Phase 2 · Highlands Oncology Group · Pfizer · NCT07227415 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Highlands Oncology Group · Novartis Pharmaceuticals · NCT05939414 Protein and Polycystic Ovary Syndrome (PCOS)
NA · Center for Human Nutrition · University of Arkansas, Fayetteville · NCT07158723 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Cross Creek Medical Clinic-Site Number: 8400057 · Sanofi · NCT07184931 A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Phase 3 · Cinical Study Site · Dianthus Therapeutics · NCT07647510 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase 2 · Highlands Oncology Group - Fayetteville · SWOG Cancer Research Network · NCT05633615 Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Inva
Phase 2 · Highlands Oncology Group - Fayetteville · National Cancer Institute (NCI) · NCT07061964 A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 · Highlands Oncology Group · Seagen, a wholly owned subsidiary of Pfizer · NCT04389632 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Highlands Oncology Group · Pfizer · NCT07222800 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Phase 3 · Coastal Research Institute, LLC · Ardelyx · NCT07382167 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Piedmont Fayette Hospital · NRG Oncology · NCT04852887

Look up another city

Look up another condition